BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 6436959)

  • 1. [Osteolysis, then fracture of the femur in a Paget's disease patient treated with high-dose disodium etidronate].
    Pinel B; Cambon C; Thomine JM; Cauvin M; Daragon A; Deshayes P
    Rev Rhum Mal Osteoartic; 1984; 51(7-8):417-8. PubMed ID: 6436959
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pseudosarcomatous osteolysis in a Paget's disease patient treated with disodium etidronate (EHDP)].
    Rondier J; Huchet B; Cayla J
    Rev Rhum Mal Osteoartic; 1984 Jan; 51(1):49-54. PubMed ID: 6420876
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pseudosarcomatous osteolysis of the femur in a patient with Paget's bone disease treated with long-term etidronate disodium: apropos of a new case].
    Marin F; Billey T; Lassoued S
    Rev Med Interne; 1996; 17(10):856-8. PubMed ID: 8976984
    [No Abstract]   [Full Text] [Related]  

  • 4. Osteolytic Paget's disease of bone under unduly etidronate therapy.
    Wendling D; Guidet M
    Clin Rheumatol; 1988 Dec; 7(4):543-5. PubMed ID: 3149926
    [No Abstract]   [Full Text] [Related]  

  • 5. Osteomalacia in a patient with Paget's bone disease treated with long-term etidronate.
    Hoppé E; Masson C; Laffitte A; Chappard D; Audran M
    Morphologie; 2012 Aug; 96(313):40-3. PubMed ID: 23022200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneous fractures of uninvolved bones in patients with Paget's disease during unduly prolonged treatment with disodium etidronate (EHDP).
    Mautalen C; Gonzalez D; Blumenfeld EL; Santini Araujo E; Schajowicz F
    Clin Orthop Relat Res; 1986 Jun; (207):150-5. PubMed ID: 3087670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etidronate disodium for Paget's disease.
    Med Lett Drugs Ther; 1978 Sep; 20(18):78-9. PubMed ID: 99647
    [No Abstract]   [Full Text] [Related]  

  • 8. Review of fracture experience during treatment of Paget's disease of bone with etidronate disodium (EHDP).
    Johnston CC; Altman RD; Canfield RE; Finerman GA; Taulbee JD; Ebert ML
    Clin Orthop Relat Res; 1983; (172):186-94. PubMed ID: 6401608
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pseudotumoral osteolysis caused by diphosphonates].
    Fedou P; Codine P; Simon L
    Rev Rhum Mal Osteoartic; 1986 Apr; 53(4):293-4. PubMed ID: 3090678
    [No Abstract]   [Full Text] [Related]  

  • 10. Etidronate disodium in the treatment of Paget's disease of bone.
    Krane SM
    Ann Intern Med; 1982 May; 96(5):619-25. PubMed ID: 6280538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term follow-up of 88 patients with Paget's disease treated by discontinuous courses of low-dose disodium etidronate].
    Ravault A; Meunier PJ
    Rev Rhum Mal Osteoartic; 1989 Mar; 56(4):293-302. PubMed ID: 2496461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneous fractures in a patient treated with low doses of etidronic acid (disodium etidronate).
    Eyres KS; Marshall P; McCloskey E; Douglas DL; Kanis JA
    Drug Saf; 1992; 7(2):162-5. PubMed ID: 1605902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of Paget's disease with the combined administration of calcitonin and disodium etidronate].
    Ghiringhelli G; Fogel M; Varela de Rodríguez J; Casco C; Mautelén C; Nusimovich B
    Medicina (B Aires); 1982; 42(1):16-20. PubMed ID: 6813634
    [No Abstract]   [Full Text] [Related]  

  • 14. Paget's disease of bone. Experience with a diphosphonate (disodium etidronate) in treatment.
    Smith R; Russell RG; Bishop MC; Woods CG; Bishop M
    Q J Med; 1973 Apr; 42(166):235-56. PubMed ID: 4206518
    [No Abstract]   [Full Text] [Related]  

  • 15. Focal osteomalacia due to low-dose diphosphonate therapy in Paget's disease.
    Boyce BF; Smith L; Fogelman I; Johnston E; Ralston S; Boyle IT
    Lancet; 1984 Apr; 1(8381):821-4. PubMed ID: 6143140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small doses of etidronate (EHDP) and Paget's disease: meaning and importance of the decrease in plasmatic 25(OH)D3.
    D'Amore M; Carrozzo M; Cantatore FP; Scagliusi P; Pipitone V
    Panminerva Med; 1984; 26(1):13-7. PubMed ID: 6233523
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of Paget's disease with low dose sodium etidronate (5mg/kg/day). Occurrence of reversible transient suspected leukopenia].
    Reginster JY; Gritten C; Diverse P; Hauwaert PC; Crielaard JM; Halleux R; Franchimont P
    Rev Rhum Mal Osteoartic; 1985 Mar; 52(3):145-50. PubMed ID: 3923603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evolution of Paget's disease of bone during and after treatment with small doses of disodium etidronate (EHDP)].
    Reginster JY; Gritten C; Diverse P; Hauwaert C; Halleux R; Franchimont P
    Rev Med Liege; 1985 May; 40(10):417-22. PubMed ID: 3927462
    [No Abstract]   [Full Text] [Related]  

  • 19. Proceedings: Treatment of Paget's disease of bone with disodium ethane-1-hydroxy-1,1-diphosphonate.
    de Vries HR; Bijvoet OL; Froeling PG
    J Endocrinol; 1975 Mar; 64(3):51P. PubMed ID: 805820
    [No Abstract]   [Full Text] [Related]  

  • 20. [A new case of pseudosarcomatous osteolysis in a patient with Paget's disease treated with disodium etidronate].
    Chapuis L; Oudry B; Jacomy LP; Lancien G; Morel B
    Presse Med; 1990 Jan 6-13; 19(1):34. PubMed ID: 2153954
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.